Find clinical trials for Lung Cancer in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Rochester, MN, USA:
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Rochester, Minnesota, United States and 83 other locations
This is a Phase 2, multi-center, open-label study to evaluate the safety and efficacy of VGT-309, a tumor-targeted, activatable fluorescent ...
Phase 2
Rochester, Minnesota, United States and 5 other locations
in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung...
Phase 1, Phase 2
Rochester, Minnesota, United States and 48 other locations
A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...
Phase 1
Rochester, Minnesota, United States and 22 other locations
combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small cell lung ...
Phase 1
Rochester, Minnesota, United States and 72 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best...
Phase 2
Rochester, Minnesota, United States and 252 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small Cell Lung...
Phase 1, Phase 2
Rochester, Minnesota, United States and 7 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer...
Phase 3
Rochester, Minnesota, United States and 284 other locations
This study will investigate the utility of biomarker-based triage for study participants with advanced non-small cell lung cancer (...
Phase 2
Rochester, Minnesota, United States and 80 other locations
in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), pl...
Phase 1
Rochester, Minnesota, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal